Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.
Tickers GILD HUGE KTTA SAGE
Tags Biotech GILD Benzinga
From Benzinga
Got $5,000? Buy and Hold These 3 Value Stocks for Years
Tickers DELL GILD HPQ TSN
Tags TSN GILD Market News
From Motley Fool
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
Tickers ADAG ALNY ARQT EXEL
Tags Small Cap VSTM GILD
From Benzinga
Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
Tickers GILD
Tags COVID/19 Coronavirus Phase 3 Trial General
From Benzinga
Price To Earnings Ratio Insights For Gilead Sciences
Tickers GILD
Tags Earnings BZI/PE News
From Benzinga
FDA Slaps Clinical Hold On Gilead's Injectable Lenacapavir In HIV Trials
Tickers GILD
Tags General Market News FDA
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
Tickers ALLK GILD GRFS IBB
Tags NVS NVAX KRMD
From Benzinga
European Commission Expands Use Of Remdesivir In COVID-19 Patients Not On Supplemental Oxygen
Tickers GILD
Tags Health Care Benzinga Biotech
From Benzinga
EMA Might Not Decide On Merck's COVID-91 Oral Antiviral Before Christmas: Reuters
Tickers GILD MRK
Tags European Medicines Agency General COVID/19 Coronavirus
From Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
Tickers GILD
Tags General ASH21 Market News
From Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
Tickers GILD
Tags Phase 3 Trial ASH21 Health Care
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
Tickers ABBV ALL ALSN AMGN
Tags DRNA Initiation JBI
From Benzinga
Why Arcus Biosciences Stock Vaulted Higher in November
Tickers GILD RCUS
Tags GILD Recent Press Releases Market News
From Motley Fool
Is Gilead Sciences Stock a Buy Now?
Tickers GILD MRK NRXP PFE
Tags NRXP MRK Market News
From Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
Tickers ACAD APTX AZN BLU
Tags GILD Biotech Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
Tickers AAL AAPL ACEL AMGN
Tags MAG PAR SEMR
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Tickers ABBV ADCT AGIO ALNY
Tags FMTX APDN DERM
From Benzinga
Gilead Recalls Two Lots Of Remdesivir Due To Presence Of Glass Particulates
Tickers GILD
Tags Market News FDA Biotech
From Benzinga
December SPAC Merger Calendar: Upcoming Votes, Stocks To Watch
Tickers AAL ADF ATHN AXP
Tags Trading Ideas solar energy ADF
From Benzinga
Got $1,000? Check Out These 3 Top Biotech Stocks
Tickers BEAM GILD VRTX
Tags Market News BEAM Recent Press Releases
From Motley Fool
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
Tickers ABBV BNTX GILD LLY
Tags BNTX ABBV Recent Press Releases
From Motley Fool
FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
Tickers GILD GSK LLY MRK
Tags GSK VIR MRK
From MarketWatch
Why NRx Pharmaceuticals Stock Soared Today
Tickers GILD NRXP
Tags GILD NRXP Recent Press Releases
From Motley Fool
Why Are NRx Pharma's Shares Soaring Premarket?
Tickers GILD NRXP
Tags GILD Benzinga Biotech
From Benzinga
3 Dividend Stocks That Are Dirt Cheap Right Now
Tickers GILD MSBI WU
Tags Market News Recent Press Releases WU
From Motley Fool
A Look Into Gilead Sciences Debt
Tickers GILD
Tags Market News BZI/Debt Benzinga
From Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
Tickers GILD MRK
Tags General Market News Phase 2 Trial
From Benzinga
Gilead's Trodelvy Approved In Europe For Aggressive Form Of Breast Cancer
Tickers GILD
Tags Market News breast cancer Health Care
From Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
Tickers AADI ABEO AMYT APLT
Tags Benzinga Earnings FDA
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
Tickers AMGN AZN BIIB BMY
Tags GILD Market News AZN
From Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.